DNA methylation array analysis identifies profiles of blood-derived DNA methylation associated with bladder cancer

Journal of Clinical Oncology

Volumn 29, Issue 9, 2011, Pages 1133-1139

  Marsit, Carmen J ^a   Koestler, Devin C ^a   Christensen, Brock C ^a   Karagas, Margaret R ^a   Houseman, E Andres ^a   Kelsey, Karl T ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BINDING SITE; BLADDER CANCER; BLOOD; CANCER RISK; CONTROLLED STUDY; CPG ISLAND; DISEASE PREDISPOSITION; DNA METHYLATION; FAMILY HISTORY; FEMALE; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING HABIT;

ADULT; AGED; CARCINOMA IN SITU; CASE-CONTROL STUDIES; CPG ISLANDS; DNA METHYLATION; DNA, NEOPLASM; EPIGENOMICS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; PROGNOSIS; ROC CURVE; URINARY BLADDER NEOPLASMS;

EID: 79952763964     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2010.31.3577     Document Type: Article

References (43)

1. Jemal A, Siegel R, Ward E, et al: Cancer statistics, 2009. CA Cancer J Clin 59:225-249, 2009
2. Parkin DM: The global burden of urinary bladder cancer. Scand J Urol Nephrol Suppl 12-20, 2008
3. Hayat MJ, Howlader N, Reichman ME, et al: Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program. Oncologist 12:20-37, 2007 (Pubitemid 46143500)
4. Botteman MF, Pashos CL, Redaelli A, et al: The health economics of bladder cancer: A comprehensive review of the published literature. Pharmacoeconomics 21:1315-1330, 2003 (Pubitemid 38041357)
5. Kogevinas M, Trichopoulos D: Urinary bladder cancer. In Adami H, Hunter DJ, Trichopoulos D (eds): Textbook of Cancer Epidemiology. London, England, Oxford University Press, 2002, pp 446-466
6. Colt JS, Baris D, Stewart P, et al: Occupation and bladder cancer risk in a population-based case-control study in New Hampshire. Cancer Causes Control 15:759-769, 2004 (Pubitemid 39335572)
7. National Research Council: Arsenic in Drinking Water. Washington, DC, National Academy Press, 2001
8. Chen Y, Ahsan H: Cancer burden from arsenic in drinking water in Bangladesh. Am J Public Health 94:741-744, 2004 (Pubitemid 38560375)
9. Smith AH, Lingas EO, Rahman M: Contamination of drinking-water by arsenic in Bangladesh: A public health emergency. Bull World Health Organ 78:1093-1103, 2000
10. Bates MN, Smith AH, Cantor KP: Case-control study of bladder cancer and arsenic in drinking water. Am J Epidemiol 141:523-530, 1995
11. Karagas MR, Tosteson TD, Morris JS, et al: Incidence of transitional cell carcinoma of the bladder and arsenic exposure in New Hampshire. Cancer Causes Control 15:465-472, 2004 (Pubitemid 39060938)
12. King WD, Marrett LD: Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control 7:596-604, 1996 (Pubitemid 26377729)
13. Wilkens LR, Kadir MM, Kolonel LN, et al: Risk factors for lower urinary tract cancer: The role of total fluid consumption, nitrites and nitrosamines, and selected foods. Cancer Epidemiol Biomarkers Prev 5:161-166, 1996
14. Mueller CM, Caporaso N, Greene MH: Familial and genetic risk of transitional cell carcinoma of the urinary tract. Urol Oncol 26:451-464, 2008
15. Engel LS, Taioli E, Pfeiffer R, et al: Pooled analysis and meta-analysis of glutathione S-transferase M1 and bladder cancer: A HuGE review. Am J Epidemiol 156:95-109, 2002 (Pubitemid 34759966)
16. Kiemeney LA, Grotenhuis AJ, Vermeulen SH, et al: Genome-wide association studies in bladder cancer: First results and potential relevance. Curr Opin Urol 19:540-546, 2009
17. Wu X, Ye Y, Kiemeney LA, et al: Genetic variation in the prostate stem cell antigen gene PSCA confers susceptibility to urinary bladder cancer. Nat Genet 41:991-995, 2009
18. Schork NJ, Murray SS, Frazer KA, et al: Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19:212-219, 2009
19. Jones PA, Laird PW: Cancer epigenetics comes of age. Nat Genet 21:163-167, 1999 (Pubitemid 29070360)
20. Gaudet F, Hodgson JG, Eden A, et al: Induction of tumors in mice by genomic hypomethylation. Science 300:489-492, 2003 (Pubitemid 36444330)
21. Christensen BC, Houseman EA, Marsit CJ, et al: Aging and environmental exposures alter tissue-specific DNA methylation dependent upon CpG island context. PLoS Genet 5:e1000602, 2009
22. Teschendorff AE, Menon U, Gentry-Maharaj A, et al: Age-dependent DNA methylation of genes that are suppressed in stem cells is a hallmark of cancer. Genome Res 20:440-446, 2010
23. Widschwendter M, Apostolidou S, Raum E, et al: Epigenotyping in peripheral blood cell DNA and breast cancer risk: A proof of principle study. PLoS One 3:e2656, 2008
24. Teschendorff AE, Menon U, Gentry-Maharaj A, et al: An epigenetic signature in peripheral blood predicts active ovarian cancer. PLoS One 4:e8274, 2009
25. Wang L, Aakre JA, Jiang R, et al: Methylation markers for small cell lung cancer in peripheral blood leukocyte DNA. J Thorac Oncol 5:778-785, 2010
26. Karagas MR, Tosteson TD, Blum J, et al: Design of an epidemiologic study of drinking water arsenic exposure and skin and bladder cancer risk in a U.S. population. Environ Health Perspect 106: 1047-1050, 1998 (suppl 4) (Pubitemid 28419791)
27. Wallace K, Kelsey KT, Schned A, et al: Selenium and risk of bladder cancer: A population-based case-control study. Cancer Prev Res (Phila Pa) 2:70-73, 2009
28. Houseman EA, Christensen BC, Yeh RF, et al: Model-based clustering of DNA methylation array data: A recursive-partitioning algorithm for high-dimensional data arising as a mixture of beta distributions. BMC Bioinformatics 9:365, 2008
29. Koestler DC, Marsit CJ, Christensen BC, et al: Semi-supervised recursively partitioned mixture models for identifying cancer subtypes. Bioinformatics 26:2578-2585, 2010
30. Bair E, Tibshirani R: Semi-supervised methods to predict patient survival from gene expression data. PLoS Biol 2:E108, 2004
31. Subramanian A, Tamayo P, Mootha VK, et al: Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A 102:15545-15550, 2005 (Pubitemid 41528093)
32. Dietrich K, Schned A, Fortuny J, et al: Glucocorticoid therapy and risk of bladder cancer. Br J Cancer 101:1316-1320, 2009
33. Loskog A, Ninalga C, Paul-Wetterberg G, et al: Human bladder carcinoma is dominated by T-regulatory cells and Th1 inhibitory cytokines. J Urol 177:353-358, 2007 (Pubitemid 44879486)
34. Wang HY, Wang RF: Regulatory T cells and cancer. Curr Opin Immunol 19:217-223, 2007 (Pubitemid 46356965)
35. Ruffell B, DeNardo DG, Affara NI, et al: Lymphocytes in cancer development: Polarization towards pro-tumor immunity. Cytokine Growth Factor Rev 21:3-10, 2010
36. Ouyang W, Beckett O, Ma Q, et al: Foxo proteins cooperatively control the differentiation of Foxp3+ regulatory T cells. Nat Immunol 11:618-627, 2010
37. Marsit CJ, Karagas MR, Andrew A, et al: Epigenetic inactivation of SFRP genes and TP53 alteration act jointly as markers of invasive bladder cancer. Cancer Res 65:7081-7085, 2005 (Pubitemid 41161235)
38. Tian G, Huang Y, Rommelaere H, et al: Pathway leading to correctly folded beta-tubulin. Cell 86:287-296, 1996 (Pubitemid 26286111)
39. Hofmann S, Lichtner P, Schuffenhauer S, et al: Assignment of the human genes coding for cytochrome c oxidase subunits Va (COX5A), VIc (COX6C) and VIIc (COX7C) to chromosome bands 15q25, 8q22->q23 and 5q14 and of three pseudogenes (COX5AP1, COX6CP1, COX7CP1) to 14q22, 16p12 and 13q14->q21 by FISH and radiation hybrid mapping. Cytogenet Cell Genet 83:226-227, 1998 (Pubitemid 29112744)
40. Dang C, Gottschling M, Manning K, et al: Identification of dysregulated genes in cutaneous squamous cell carcinoma. Oncol Rep 16:513-519, 2006
41. De Angelis PM, Svendsrud DH, Kravik KL, et al: Cellular response to 5-fluorouracil (5-FU) in 5-FUresistant colon cancer cell lines during treatment and recovery. Mol Cancer 5:20, 2006
42. Wu X, Hildebrandt MA, Chang DW: Genomewide association studies of bladder cancer risk: A field synopsis of progress and potential applications. Cancer Metastasis Rev 28:269-280, 2009
43. Wu X, Lin J, Grossman HB, et al: Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 25:4974-4981, 2007 (Pubitemid 350220430)